Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Call for action: expanding global access to hereditary cancer genetic testing.
Bychkovsky B, Rana HQ, Ademuyiwa F, Plichta J, Anderson K, Nogueira-Rodrigues A, Santa-Maria CA, Coffman LG, Marquez C, Das A, Taghian A, Koeller DR, Sandoval RL, Park BH, Dizon DS. Bychkovsky B, et al. Among authors: coffman lg. Lancet Oncol. 2022 Sep;23(9):1124-1126. doi: 10.1016/S1470-2045(22)00378-3. Lancet Oncol. 2022. PMID: 36055301 No abstract available.
Stromal mediated DNA damage promotes high grade serous ovarian cancer initiation.
Garcia GL, Orellana T, Gorecki G, Frisbie LG, Baruwal R, Goldfield E, Beddows I, MacFawn IP, Britt AK, Hale MM, Shen H, Buckanovich R, Finkel T, Drapkin R, Soong TR, Bruno TC, Atiya HI, Coffman L. Garcia GL, et al. Among authors: coffman l. bioRxiv [Preprint]. 2024 May 28:2024.05.23.595550. doi: 10.1101/2024.05.23.595550. bioRxiv. 2024. PMID: 38853994 Free PMC article. Preprint.
Drp1 splice variants regulate ovarian cancer mitochondrial dynamics and tumor progression.
Javed Z, Shin DH, Pan W, White SR, Elhaw AT, Kim YS, Kamlapurkar S, Cheng YY, Benson JC, Abdelnaby AE, Phaëton R, Wang HG, Yang S, Sullivan MLG, St Croix CM, Watkins SC, Mullett SJ, Gelhaus SL, Lee N, Coffman LG, Aird KM, Trebak M, Mythreye K, Walter V, Hempel N. Javed Z, et al. Among authors: coffman lg. EMBO Rep. 2024 Oct;25(10):4281-4310. doi: 10.1038/s44319-024-00232-4. Epub 2024 Aug 27. EMBO Rep. 2024. PMID: 39191946 Free PMC article.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
Novel Therapies in Gynecologic Cancer.
Bejar FG, Oaknin A, Williamson C, Mayadev J, Peters PN, Secord AA, Wield AM, Coffman LG. Bejar FG, et al. Among authors: coffman lg. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-17. doi: 10.1200/EDBK_351294. Am Soc Clin Oncol Educ Book. 2022. PMID: 35594502 Free article.
Clinical factors associated with failed sentinel lymph node mapping in endometrial cancer.
Garrett AA, Wield A, Mumford B, Janmey I, Wang L, Grosse P, MacArthur E, Buckanovich R, Courtney-Brooks M, Sukumvanich P, Berger J, Olawaiye AB, Mahdi H, Boisen M, Edwards RP, Coffman L, Taylor SE, Lesnock J. Garrett AA, et al. Gynecol Oncol Rep. 2022 Oct 7;44:101080. doi: 10.1016/j.gore.2022.101080. eCollection 2022 Dec. Gynecol Oncol Rep. 2022. PMID: 36249905 Free PMC article.
43 results